Aarti Pharmalabs Limited — Board Meeting, 09-02-2026: Outcome of Board Meeting
09-02-2026 | 08:15 pm
09-02-2026 | 08:15 pm
Aarti Pharmalabs' board approved consolidated Q3 FY26 net profit of ₹4.80 Cr and 9M FY26 net profit of ₹12.50 Cr. An interim dividend of ₹1.50/share (30%) for FY26 was declared, with Feb 16, 2026, as the record date. #StockMarket #Dividends
No comments yet. Be the first to comment!
